NCT02126189

Brief Summary

This study is designed to refine the aetiological causes of cancers of the head and neck and investigate the ways in which human papillomavirus and life-style factors cause head and neck cancers. This study will determine if these factors affect the treatment of cancer. All patients attending the Head and Neck Clinic at the Princess Alexandra Hospital is invited to complete a risk factor questionnaire and give consent for their clinical data and tissue samples to be available for future research activities. The risk factor questionnaire is based on existing validated instruments developed by the QIMR Berghofer Medical Research Institute Cancer Control Group, and will collect standardised information relating to demographics and causal factors (tobacco and alcohol intake), risk modifiers (dentition, asprin and non-steroidal anti-inflammatory drugs (NSAIDS), height, weight, physical activity, diet quality etc) and behaviours (oral sex etc)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 23, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 29, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

April 22, 2015

Status Verified

April 1, 2015

Enrollment Period

3 years

First QC Date

April 23, 2014

Last Update Submit

April 20, 2015

Conditions

Keywords

Head and Neck Squamous Cell CarcinomaHuman PapillomavirusAetiologyprevalencerisk factorsclinical outcome

Outcome Measures

Primary Outcomes (1)

  • To identify exposures associated with an increased risk of head and neck squamous cell carcinoma

    2 years

Other Outcomes (3)

  • To compare subjects who have ever been exposed with those who have never been exposed.

    2 years

  • To estimate the effect of each exposure adjusted for the confounding effects of other exposures.

    2 years

  • To test for trends in head and neck squamous cell carcinoma

    2 years

Study Arms (1)

Head and neck cancer

All patients presenting to the Head and Neck Cancer Clinic at the Princess Alexandra Hospital, Brisbane, Australia are invited to participate.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients presenting to the Head and Neck Cancer Clinic at the Princess Alexandra Hospital, Brisbane, Australia. Patients may be be new patients or old patients and may have a new diagnosis or they may have a recurrence.

You may qualify if:

  • All patients presenting to the Head and Neck Cancer Clinic at the Princess Alexandra Hospital Brisbane Australia.

You may not qualify if:

  • nil

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Princess Alexandra Hospital

Brisbane, Queensland, 4102, Australia

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Participants are asked to give their consent for researchers to obtain tissue from tumour blocks. This tissue is taken as part of their normal care and treatment. If consent is given, formalin-fixed paraffin embedded (FFPE) tissue samples will be used to determine HPV status.

MeSH Terms

Conditions

Squamous Cell Carcinoma of Head and Neck

Condition Hierarchy (Ancestors)

Carcinoma, Squamous CellCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsHead and Neck NeoplasmsNeoplasms by Site

Study Officials

  • Annika Antonsson, Dr

    QIMR Berghofer Medical Research Institute

    PRINCIPAL INVESTIGATOR
  • Ben Panizza, Assoc Prof

    Princess Alexandra Hospital

    PRINCIPAL INVESTIGATOR
  • Sandro Porceddu, Assoc Prof

    Princess Alexandra Hospital

    PRINCIPAL INVESTIGATOR
  • David Whiteman, Prof

    QIMR Berghofer Medical Research Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2014

First Posted

April 29, 2014

Study Start

November 1, 2013

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

April 22, 2015

Record last verified: 2015-04

Locations